Bert W OMalley Jr
Overview
Explore the profile of Bert W OMalley Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
2589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miranda S, Blue R, Parasher A, Lerner D, Glicksman J, Detchou D, et al.
World Neurosurg
. 2023 Jan;
172:e357-e363.
PMID: 36640831
Background: We implemented a streamlined care pathway for patients undergoing endoscopic transsphenoidal (TSA) pituitary surgery. Select patients are recovered in the postanesthesia care unit and transferred to a step-down unit...
2.
Parasher A, Lerner D, Miranda S, Douglas J, Glicksman J, Alexander T, et al.
Am J Rhinol Allergy
. 2022 Dec;
37(3):324-329.
PMID: 36529537
Objective: To determine the in-hospital cost implications of an endoscopic expanded endonasal approach (EEEA) for meningioma resection relative to the open transcranial approach. Methods: All anterior skull base meningioma surgeries...
3.
Generotti C, Cox B, Singh J, Hamilton D, McKenzie E, OMalley Jr B, et al.
Sci Rep
. 2022 Oct;
12(1):18032.
PMID: 36302835
A mouse model with cisplatin-induced ototoxicity was used in addition to human samples from the ITMAT Biobank at the University of Pennsylvania. Mouse auditory brainstem responses (ABR), inner ear histology,...
4.
Yver C, Chao T, Thaler E, Ruckenstein M, Chalian A, Weinstein G, et al.
World J Otorhinolaryngol Head Neck Surg
. 2022 Aug;
PMID: 35942327
Objective: To quantify the financial impact of the coronavirus disease (COVID-19) pandemic on an academic otolaryngology department. Methods: A year-over-year comparison was used to compare department revenue from April 2020...
5.
Parasher A, Lerner D, Miranda S, Douglas J, Glicksman J, Alexander T, et al.
Laryngoscope
. 2022 Aug;
133(1):83-87.
PMID: 35929639
Objective: To determine the in-hospital cost implications of an expanded endoscopic endonasal approach (EEEA) for craniopharyngioma resection relative to the traditional open transcranial approach. Methods: All craniopharyngioma surgeries performed at...
6.
Anagnos V, Brody R, Carey R, De Ravin E, Tasche K, Newman J, et al.
Ann Otol Rhinol Laryngol
. 2022 Apr;
132(3):310-316.
PMID: 35473389
Objectives: To determine whether 2 different methods of post-operative head and neck free flap monitoring affect flap failure and complication rates. Methods: A retrospective chart review of 803 free flaps...
7.
Ferris R, Flamand Y, Weinstein G, Li S, Quon H, Mehra R, et al.
J Clin Oncol
. 2021 Oct;
40(2):138-149.
PMID: 34699271
Purpose: Definitive or postoperative chemoradiation (CRT) is curative for human papillomavirus-associated (HPV+) oropharynx cancer (OPC) but induces significant toxicity. As a deintensification strategy, we studied primary transoral surgery (TOS) and...
8.
Chao T, Kuan E, Tong C, Kohanski M, Grady M, Palmer J, et al.
J Neurol Surg B Skull Base
. 2021 Jul;
82(Suppl 3):e148-e154.
PMID: 34306930
Surgical resection is widely accepted as a critical component for definitive treatment of sinonasal mucosal melanoma. Systemic immunotherapy, including multiple newer agents, has been used to treat metastatic or unresectable...
9.
Sun L, Shimunov D, Tan E, Swisher-McClure S, Lin A, Lukens J, et al.
Head Neck
. 2021 Jun;
43(10):3053-3061.
PMID: 34170052
Background: Patients with oropharyngeal cancer who undergo transoral robotic surgery (TORS) and have high-risk features generally receive adjuvant chemoradiotherapy or trimodality therapy (TMT). The notion that TMT leads to high...
10.
Parhar H, Weinstein G, OMalley Jr B, Shimunov D, Rassekh C, Chalian A, et al.
Head Neck
. 2021 Jun;
43(10):2923-2934.
PMID: 34101290
Background: Patients with human papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) continue to experience disappointing outcomes following chemoradiotherapy (CRT) and appreciable morbidity following historical surgical approaches. We aimed to investigate...